Abstracts (HTML) List of Authors

Pabinger, I

Increased soluble thrombomodulin influences fibrin clot formation in patients with mild to moderate bleeding tendency
Long-term efficacy and safety of rIX-FP prophylaxis in adult patients with haemophilia B on a 21-day dosing regimen
Growth differentiation factor-15 predicts major cardiac adverse events and all-cause mortality in patients with atrial fibrillation
Anticoagulation for stroke prevention in patients with atrial fibrillation on hemodialysis is associated with net-clinical harm
Factors influencing bleeding severity in adult patients with primary immune thrombocytopenia

Palankar, R

Low adhesion and interaction forces of Myh9 mutant platelets lead to impaired clot retraction and unstable thrombus formation
Platelets from patients with MYH9 related disorders are mechanically stiffer
Antibodies protect platelet damage by pneumolysin

Panicot-Dubois, L

Evolution of platelet phenotype during SARS-CoV-2 infection

Papa, N

Functional assays to unravell the pathogenetic role of variants found in GFI1B in piastrinopenic patients

Papageorgiou, C

Derivation and Validation of a Predictive Score for Disease Worsening in Patients with COVID-19

Papageorgiou, L

International Myeloma Working Group (IMWG) score accuracy in multiple myeloma patients: need for action
Differences in the coagulation profile in women with mild and severe eclampsia
Derivation and Validation of a Predictive Score for Disease Worsening in Patients with COVID-19
Analysis of adherence to therapy comparing DOAC Dipstick test with plasma concentration of rivaroxaban and apixaban in outpatients with venous thromboembolic disease

Papajík, T

The occurrence of trombocythopathy in CLL patients treated with Ibrutinib

Paric, L

Comparing automated FXIII assays

Parrot, A

Derivation and Validation of a Predictive Score for Disease Worsening in Patients with COVID-19

Pasi, KJ

Long-term Efficacy and Safety of Fitusiran in Participants with Hemophilia A and B: An Interim Analysis of the Phase 1/2 Open-Label Extension Study

Pasterk, L

Dietary omega-3 fatty acid reverses age-associated platelet hyperreactivity through modulation of gut microbiota

Pastore, A

The Glycosylation Nexus Enigma: new clues to the role of the GNE gene in the pathogenesis of inherited thrombocytopenia in both isolated and myopathy-associated forms

Pavlova, A

Thrombophilic Phaenotype in a Family with High Frequency of Homozygous Antithrombin Deficiency Typ IIb Budapest 3 and Mild Factor VII Deficiency due to Homozygous Polymorphisms in the Factor 7 Gene and Antithrombotic Treatment
Type 2B von Willebrand disease – a rare cause of neonatal thrombocytopenia

Paz Rios, LH

Implementation of Direct Oral Anticoagulant (DOAC) Perioperative Interruption and Interval evaluation of the DOASENSE Dipstick performance

Pecci, A

Functional assays to unravell the pathogenetic role of variants found in GFI1B in piastrinopenic patients
Intracranial involvement and neurologic manifestations in Lemierre syndrome: analysis of 712 patients.

Peine, S

Characterization of activity and cleavage of von Willebrand disease type 2B variants

Peiretti, F

GATA1 pathogenic variants disrupt MYH10 silencing during megakaryopoiesis

Pekrul, I

A novel approach to laboratory assessment of platelet von Willebrand factor

Pelzl, L

Platelet activation and apoptosis in COVID-19 infection: data from an observational study

Persico, I

The Glycosylation Nexus Enigma: new clues to the role of the GNE gene in the pathogenesis of inherited thrombocytopenia in both isolated and myopathy-associated forms

Pestel, S

Characterization of rFIX fusion proteins enabling subcutaneous administration
In vitro characterization of K5A and K5R variants of Factor IX

Petros, S

Enhanced prothrombotic state in patients with severe COVID-19

Peyvandi, F

Efficacy and Safety of Human Fibrinogen Concentrate in Patients with Congenital Fibrinogen Deficiency: Combined Results of the FORMA-02 and FORMA-04 Clinical Trials
Human Fibrinogen Concentrate for Bleeding Prophylaxis During Surgery in Paediatric Patients with Congenital Fibrinogen Deficiency

Pezeshkpoor, B

Thrombophilic Phaenotype in a Family with High Frequency of Homozygous Antithrombin Deficiency Typ IIb Budapest 3 and Mild Factor VII Deficiency due to Homozygous Polymorphisms in the Factor 7 Gene and Antithrombotic Treatment

Pfrepper, C

Real-world experience on the use of rIX-FP in patients with haemophilia B: Interim results from a prospective, non-interventional, post-market surveillance study in Germany

Pialloux, G

Derivation and Validation of a Predictive Score for Disease Worsening in Patients with COVID-19

Pillny, C

Thrombophilic Phaenotype in a Family with High Frequency of Homozygous Antithrombin Deficiency Typ IIb Budapest 3 and Mild Factor VII Deficiency due to Homozygous Polymorphisms in the Factor 7 Gene and Antithrombotic Treatment

Pink, M

Performance evaluation of the BIOPHEN chromogenic test for Factor XIII activity on the Cobas c502 System

Pipe, SW

Gene Transfer with Etranacogene dezaparvovec (AAV5-Padua hFIX variant) in Adults with Severe or Moderate-Severe Hemophilia B: Two Year Data from a Phase 2b Trial
Long-term Efficacy and Safety of Fitusiran in Participants with Hemophilia A and B: An Interim Analysis of the Phase 1/2 Open-Label Extension Study

Plath, M

Treatment of immune thrombocytopenia (ITP) with Eltrombopag – results of the 3 rd interim analysis of the German non-interventional trial RISA. Focussing on steroid-pretreatment and fatigue

Poggi, M

GATA1 pathogenic variants disrupt MYH10 silencing during megakaryopoiesis

Pohl, S

The contribution of bile acid transport and endoplasmatic reticulum stress to tissue factor activation in hepatocytes

Pollich, C

LMWH or DOACs for cancer associated thrombosis (CAT) in daily clinical practice ? – Insights from the GECAT registry

Poloskey, S

Long-term Efficacy and Safety of Fitusiran in Participants with Hemophilia A and B: An Interim Analysis of the Phase 1/2 Open-Label Extension Study

Pongérard, A

Human platelets labeled at two discrete biotin densities are functional in vitro and are detected in vivo in the mouse circulation. A promising approach to monitor in vivo platelet survival in clinical research
Removal of citrate from PAS-III additive solution improves functional and biochemical characteristics of buffy-coat platelet concentrates stored for seven days, with or without Intercept pathogen reduction

Ponnuswamy, P

In vitro characterization of K5A and K5R variants of Factor IX

Pötzsch, B

Aptamer-based ex vivo monitoring of thrombin and activated protein C generation on blood outgrowth endothelial cells for individualized assessment of the protein C pathway

Poveda, JL

A matching‐adjusted indirect comparison in patients with severe haemophilia A: Comparing the efficacy and consumption of rVIII-SingleChain vs two recombinant FVIII

Proamer, F

Human platelets labeled at two discrete biotin densities are functional in vitro and are detected in vivo in the mouse circulation. A promising approach to monitor in vivo platelet survival in clinical research

Prochazkova, J

Detection thrombogenicity antiphospolipid antibodies with APC modified TGT
Non-criteria antiphospholipid antibodies anti-PT/PS, anti-Anexin V: benefit in diagnostics of antiphospholipid syndrome?

Prohászka, ZZ

Prothrombotic alterations of von Willebrand factor level and ADAMTS13 activity in hospitalized COVID-19 patients

Prudent, M

Evaluation of different processing methods to label platelets for in vivo studies

Psaltopoulou, T

Derivation and Validation of a Predictive Score for Disease Worsening in Patients with COVID-19

Puceat, M

GATA1 pathogenic variants disrupt MYH10 silencing during megakaryopoiesis

Pugin, B

Dietary omega-3 fatty acid reverses age-associated platelet hyperreactivity through modulation of gut microbiota